首页 › 基金 › Winning Points Advisors, LLC › IBRX
Winning Points Advisors, LLC 对 IBRX 的持仓历史
IMMUNITYBIO INC · 医疗保健
Winning Points Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 IBRX(IMMUNITYBIO INC)730,458 股,市值约 US$6.9M,约占其申报组合的 6.09%,在其申报持仓中市值排名第 4 位。 Winning Points Advisors, LLC 最近 9 个申报季度中有 5 个季度披露了 IBRX 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Winning Points Advisors, LLC 对 IBRX 的持仓演变
Winning Points Advisors, LLC 于 Q3 2024 首次披露 IBRX 持仓:89,396 股(约 US$143K)。 该持仓在 Q3 2026 达到峰值 730,458 股,市值约 US$6.9M。 在 5 次申报中,Winning Points Advisors, LLC 2 次增持、0 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 730,458 股、市值约 US$6.9M,环比增持 4,200 股。。 持仓曾出现大幅变动:Q4 2025 增持约 708% (随后一个季度股价上涨 287%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 89.40K | $143.03K | 新进 |
| Q4 2025 | 722.37K | $509.00K | 增持 |
| Q1 2026 | 723.57K | $5.32M | 持有 |
| Q2 2026 | 726.26K | $2.29M | 持有 |
| Q3 2026 | 730.46K | $6.91M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IBRX 与 13F 数据
IBRX(IMMUNITYBIO INC)属于医疗保健行业。我们追踪的基金中还有 67 只申报持有 IBRX,申报仓位最大的包括:GREAT POINT PARTNERS LLC (US$28.3M), Sound Capital Solutions LLC (US$9.4M), Clearwater Capital Advisors, LLC (US$6.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IBRX 的基金
- GREAT POINT PARTNERS LLC 3.00M 股 · $28.33M · Q3 2026
- Sound Capital Solutions LLC 998.79K 股 · $9.43M · Q3 2026
- Clearwater Capital Advisors, LLC 717.52K 股 · $6.77M · Q3 2026
- ALLEN HOLDING INC /NY 687.57K 股 · $6.49M · Q3 2026
- Kercheville Advisors, LLC 613.38K 股 · $5.79M · Q3 2026
- SHEETS SMITH WEALTH MANAGEMENT 512.57K 股 · $4.84M · Q3 2026
- Legacy Capital Group California, Inc. 446.00K 股 · $4.21M · Q3 2026
更多关于 Winning Points Advisors, LLC
常见问题
How long has Winning Points Advisors, LLC held IBRX?
Winning Points Advisors, LLC has disclosed IBRX holdings in 5 of the last 9 reported quarters, going back to Q3 2024.
What is Winning Points Advisors, LLC's current position in IBRX?
As of Q3 2026, Winning Points Advisors, LLC holds 730.46K shares of IBRX (IMMUNITYBIO INC), valued at $6.91M, representing 6.09% of its reported portfolio and ranking #4.
Has Winning Points Advisors, LLC been buying or selling IBRX?
In the latest 13F filing (Q3 2026), Winning Points Advisors, LLC increased its position in IBRX. The position peaked in Q3 2026 at 730.46K shares.
Which other funds hold IBRX?
Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, Sound Capital Solutions LLC, Clearwater Capital Advisors, LLC, among 67 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.